THE Government is promising to roll out a programme to make a drug which can reduce a man’s risk of HIV more affordable.
Pre-exposure prophylaxis, or PrEP, is for men at risk of HIV. It is a combination of two anti-HIV drugs — emtricitabine and tenofovir.
Studies have shown that it is around 86pc effective at protecting men who have unprotected sex with men from HIV infection.
It can be used in two ways: daily, or on a sexual event basis — using it during periods of unprotected sex (for two days before, each day that unprotected sex takes place, and two days afterwards). A generic version is available now.
HIV is continuing to rise in Ireland. Some 508 new cases were notified in 2016 — a 5pc annual increase.